Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Revance Therapeutics, Inc.

Get SEC filing alerts via email and in your feed for Revance Therapeutics, Inc.

RVNC

Revance Therapeutics, Inc.

About Revance Therapeutics, Inc.

Revance Therapeutics is a biotechnology company specializing in aesthetic and therapeutic neuromodulator products, including DAXXIFY and the RHA Collection of dermal fillers. The company develops, manufactures, and commercializes innovative injectables for facial wrinkles, muscle disorders, and other indications. It partners globally for distribution and biosimilar development, focusing on long-lasting, natural-looking treatments that enhance patient and physician experiences across markets.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Revance Therapeutics, Inc.

1
1
Revance Therapeutics, Inc. Revance Therapeutics Reports 10% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments